SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-010100
Filing Date
2024-02-28
Accepted
2024-02-28 16:21:08
Documents
17
Period of Report
2024-02-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20022642_8k.htm   iXBRL 8-K 46432
2 EXHIBIT 10-1 ef20022642_ex10-1.htm EX-10.1 74731
3 EXHIBIT 99.1 ef20022642_ex99-1.htm EX-99.1 10659
7 image00001.jpg GRAPHIC 5125
  Complete submission text file 0001140361-24-010100.txt   301538

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adma-20240226.xsd EX-101.SCH 3880
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20240226_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20240226_pre.xml EX-101.PRE 16054
19 EXTRACTED XBRL INSTANCE DOCUMENT ef20022642_8k_htm.xml XML 4059
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 24695740
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)